MaxVal Group, Inc. – Trademark Portfolio
Entity Type: 03
MaxVal Group, Inc. has 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include SYMPHONY. The portfolio includes 1 registered trademark. Filings span 4 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in Los Altos, CA.
2251 Grant rd.
Suite B
Los Altos, CA 94024
Showing of trademarks Trademarks
Trademark Classifications
MaxVal Group, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does MaxVal Group, Inc. have?
MaxVal Group, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does MaxVal Group, Inc. file in?
MaxVal Group, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services). Class 35 covers advertising; business management; business administration; office functions.
What are MaxVal Group, Inc.'s most well-known trademarks?
MaxVal Group, Inc.'s registered trademark portfolio includes well-known marks such as SYMPHONY. These are among 1 currently registered trademark in the portfolio.
What is MaxVal Group, Inc.'s trademark registration success rate?
MaxVal Group, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.